A device for metering fluids comprising a fluid chamber with one inlet or outlet port, at least one sidewall and a movable separator that is in contact with and separates the fluid in the chamber from the other components of the device, a porous actuator housing and wicking material, a flexible polymer actuator material in contact with the porous actuator housing and the moveable separator, an actuator hydrating solution reservoir with at least one sidewall, an inlet port, and in fluid contact with porous actuator housing, a fluid gate located at some point between actuator hydrating solution reservoir and the polymer actuator, effectively keeping actuator dry, and an external shell to hold all components so that the polymer actuator can only move in a direction and apply pressure to the separator in contact with the fluid in the fluid chamber, thereby dispensing fluid from fluid chamber.

Patent
   9995295
Priority
Dec 03 2007
Filed
Dec 03 2008
Issued
Jun 12 2018
Expiry
Feb 19 2030
Extension
443 days
Assg.orig
Entity
Small
0
346
currently ok
20. A device for metering fluids comprising two or more separate fluid chambers with at least one fluid inlet or fluid outlet port, at least one chamber wall and a movable separator that is in contact with and retains the fluid in the fluid chambers, a porous media substrate and wicking material, an actuator formed of a flexible polymer material in contact with the porous media substrate and with the movable separators, an actuator hydrating solution reservoir bounded by said at least one chamber wall and a hydrating solution inlet port, in fluid contact with the porous media substrate, a fluid gate located between each actuator hydrating solution reservoir, and the actuator, contained in an external shell so that the actuator is adapted to move in a direction and apply pressure to the separator in contact with the fluid in the fluid chambers, thereby dispensing fluid from the fluid chambers, wherein the actuator is formed of a material having varying layers of density and porosity or varying degrees of reacted and unreacted molecular sites.
1. A device for metering a fluid comprising a walled fluid chamber with at least one fluid inlet or fluid outlet port, at least one chamber wall and a movable separator that is in contact with and retains the fluid in the chamber, a porous media substrate and a wicking material, an actuator formed of a flexible polymer material in contact with the porous media substrate and with the moveable separator, an actuator hydrating solution reservoir bounded by said at least one chamber wall and a hydrating solution inlet port, in fluid contact with the porous media substrate, a fluid gate located between the actuator hydrating solution reservoir and the polymer actuator, effectively keeping the actuator dry, contained in an external shell so that the actuator is adapted to move in a direction and apply pressure to the separator in contact with the fluid in the fluid chamber, thereby dispensing fluid from the fluid chamber, wherein the actuator is formed of a material having varying layers of density and porosity or varying degrees of reacted and unreacted molecular sites.
40. A device for metering fluids comprising two or more separate fluid walled chambers with one or more fluid inlet or fluid outlet ports that are in fluid connection with a mixing chamber, and have at least one chamber wall and a movable separator that is in contact with and retains the fluid in the fluid chambers, said outlet port being in fluid contact with tubing or fluid channel to transport mixed fluids to a desired delivery site; a porous media substrate and wicking material, an actuator formed of a flexible polymer material in contact with a porous media substrate and with the moveable separators, an actuator hydrating solution reservoir bounded by said at least one chamber wall and a hydrating solution inlet port, in fluid contact with the porous media substrate, a fluid gate located between each actuator hydrating solution reservoir and the actuator, contained in an external shell so that the actuator is adapted to move in a direction and apply pressure to the separator in contact with the fluid in the fluid chamber, thereby dispensing fluid from the fluid chambers wherein the actuator is formed of a material having varying layers of density and porosity or varying degrees of reacted and unreacted molecular sites.
2. The device in claim 1 wherein the actuator hydrating solution has a pH or chemical makeup that effects a speed and pressure generation of the actuator material.
3. The device in claim 2, wherein the device is adapted to be implanted in a person or animal and utilizes body fluids as the actuator hydrating solution and the said hydrating inlet port in the exterior shell allows the uptake of fluids by the actuator material.
4. The device as claimed in claim 1, wherein the fluid chamber and/or the actuator is removable.
5. The device as claimed in claim 1, wherein the fluid chamber and/or the porous actuator housing is made of a material selected from the group consisting of a plastic, a metal, glass, a ceramic, a carbon or a combination thereof.
6. The device as claimed in claim 1, wherein the fluid chamber inlet and/or outlet port is capped or sealed by a pierceable septum.
7. The device as claimed in claim 1, wherein the movable separator is a rubber plunger.
8. The device as claimed in claim 1, wherein the movable separator is an elastomeric membrane and also a part of or attached to the fluid chamber.
9. The device as claimed in claim 1, wherein the actuator is formed of a hydrophilic polymer material or a combination of a hydrophilic material and an hydrophobic polymer material.
10. The device as claimed in claim 1, wherein the actuator, fluid gate, porous media substrate, and actuator hydrating solution reservoir are enclosed together as a sealed unit with an elastic membrane in contact with the actuator, and said hydrating solution inlet port is covered by a pierceable septum that allows filling and venting of the actuator hydrating solution reservoir with actuator hydrating solution.
11. The device as claimed in claim 1, wherein the fluid gate is compromisable by breaking, piercing, dissolving, tearing, pushing or pulling the gate out of the actuator hydrating solution to allow hydration of the actuator material.
12. The device as claimed in claim 1, wherein the fluid gate is a membrane.
13. The device as claimed in claim 1, wherein the fluid in the fluid chamber is a medicine or has therapeutic value.
14. The device as claimed in claim 1, wherein the fluid gate is adapted to be pierced and fluid released into tubing adapted for contact with a person or animal.
15. The device as claimed in claim 1, wherein the actuator hydrating solution has a ratio of reacted to unreacted molecular sites that effects a speed and pressure generation of the actuator.
16. The device as claimed in claim 1, wherein protonation of reactive molecular sites within the actuator material, by interaction with the actuator hydrating solution or chemical byproduct of that interaction, effects a speed and pressure generation of the actuator.
17. The device as claimed in claim 1, wherein a density or porosity of the actuator material effects a speed and pressure generation of the actuator.
18. The device as claimed in claim 1, wherein an amount of surface area of actuator surface in fluid contact with the actuator hydrating solution via the porous a wicking material effects a speed and pressure generation of the actuator.
19. The device as claimed in claim 1, wherein the device is adapted to be implanted into a person or animal.
21. The device as claimed in claim 20, wherein the actuator hydrating solution pH or chemical makeup effects a speed and pressure generation of the actuator material.
22. The device as claimed in claim 21, wherein the device is adapted to be implanted into a person or animal, and utilizes body fluids as the actuator hydrating solution and the said hydrating inlet port in the exterior shell allows the uptake of body fluids by the actuator material.
23. The device as claimed in claim 20, wherein multiple types of medication, gene therapies or proteins are metered to a patient at a desired site on or in the patient.
24. The device as claimed in claim 20, wherein one or more of the fluid chambers and/or the porous actuator housing are made of a material selected from the group consisting of a plastic, a metal, glass, a ceramic, a carbon or a combination thereof.
25. The device as claimed in claim 20, wherein one or more of the fluid chambers inlet and/or outlet ports are capped or sealed by a pierceable septum.
26. The device as claimed in claim 20, wherein the movable separator is a rubber plunger.
27. The device as claimed in claim 20, wherein the movable separator is an elastomeric membrane and also a part of the fluid chamber.
28. The device as claimed in claim 20, wherein the actuator is formed of a hydrophilic polymer material or a combination of a hydrophilic and hydrophobic material.
29. The device as claimed in claim 20, wherein the actuator, fluid gate, the porous media substrate, and the actuator hydrating solution reservoir are enclosed together as a sealed unit with said movable separator in contact with the actuator with a port covered by a pierceable septum that allows filling and venting of the actuator hydrating solution reservoir with actuator hydrating solution.
30. The device as claimed in claim 20, wherein the fluid gate is compromisable by breaking, piercing, dissolving, tearing, pushing or pulling the gate out of way of the actuator hydrating solution to allow hydration of the actuator material.
31. The device as claimed in claim 20, wherein the fluid gate is a membrane.
32. The device as claimed in claim 20, wherein the fluids in the fluid chambers are a medicine or have a therapeutic value.
33. The device as claimed in claim 20, wherein the fluid gate is adapted to be pierced and fluid released into tubing that is in contact with a person or animal.
34. The device as claimed in claim 20, wherein the actuator is formed of an epoxy material.
35. The device as claimed in claim 20, wherein the actuator hydrating solution has a ratio of reacted to unreacted molecular sites that effects a speed and pressure generation of the actuator.
36. The device as claimed in claim 20, wherein a density or porosity of the actuator material effects a speed and pressure generation of the actuator.
37. The device as claimed in claim 20, wherein an amount of surface area of actuator surface in fluid contact with the actuator hydrating solution via the wicking material effects a speed and pressure generation of the actuator.
38. The device as claimed in claim 20, wherein the actuator comprises a bundle of two or more actuators formed of different materials providing different speeds and pressures for the fluid chambers.
39. The device as claimed in claim 20, wherein the device is adapted to be implanted into a person or animal.
41. The device as claimed in claim 40, wherein the actuator hydrating solution pH or chemical makeup effects a speed and pressure generation of the actuator material.
42. The device as claimed in claim 41, wherein the device is adapted to be implanted in the body of a person or animal, and utilizes body fluids as the actuator hydrating solution and said hydrating inlet port in the exterior shell that allows an uptake of body fluids by the actuator material.
43. The device as claimed in claim 40, wherein multiple types of medication, gene therapies or proteins are metered to a patient at a desired site on or in the patient.
44. The device as claimed in claim 40, wherein one or more of the fluid chambers and/or the porous media substrate are made of a material selected from a plastic, a metal, glass, a ceramic, a carbon or a combination thereof.
45. The device as claimed in claim 40, wherein one or more of the fluid chambers inlet and/or outlet ports are capped or sealed by a pierceable septum.
46. The device as claimed in claim 40, wherein the movable separator is a rubber plunger.
47. The device as claimed in claim 40, wherein the movable separator is an elastomeric membrane and also a part of the fluid chamber.
48. The device as claimed in claim 40, wherein the polymer actuator is formed of an hydrophilic material or a combination of an hydrophilic and an hydrophobic material.
49. The device as claimed in claim 40, wherein the actuator, fluid gate, the porous media substrate, and the actuator hydrating solution reservoir are enclosed together as a sealed unit with the movable separator in contact the with actuator, with the hydration solution inlet port covered by a pierceable septum that allows filling and venting of the actuator hydrating solution reservoir with actuator hydrating solution.
50. The device as claimed in claim 40, wherein the fluid gate is compromisable by breaking, piercing, dissolving, tearing, pushing or pulling the fluid gate out of the actuator hydrating solution path to allow hydration of the actuator material.
51. The device as claimed in claim 40, wherein the fluid gate is a membrane.
52. The device as claimed in claim 40, wherein the fluids in the fluid chambers are a medicine or have therapeutic value.
53. The device as claimed in claim 40, wherein the fluid inlet or outlet port is capped or sealed by a septum adapted to be pierced and fluid released into tubing adapted for contact with a person or animal.
54. The device as claimed in claim 40, wherein the actuator is formed of an epoxy material.
55. The device as claimed in claim 40, wherein the actuator hydrating solution has a ratio of reacted to un-reacted molecular sites that effects a speed and pressure generation of the actuator material.
56. The device as claimed in claim 40, wherein a density or porosity of the actuator material effects a speed and pressure generation of the actuator material.
57. The device as claimed in claim 40, wherein an amount of surface area of actuator surface in fluid contact with the actuator hydrating solution via the porous actuator housing wicking material effects a speed and pressure generation of the actuator.
58. The device as claimed in claim 40, wherein there are two or more different actuator materials which effect speeds and pressures for the fluid chambers.
59. The device as claimed in claim 40, wherein the device is adapted to be implanted into a person or animal.

This application claims priority from PCT Patent Application Serial No. PCT/US08/85421 filed Dec. 3, 2008, which claims priority from U.S. Provisional Application Ser. No. 60/992,003, filed Dec. 3, 2007, the contents of which are incorporated herein by reference.

The invention is a fluid metering device or pump that can deliver a pre-determined volume of fluid at a pre-determined pressure at a pre-determined rate of delivery. The device can be pre filled with the fluid during the manufacturing process or the device can be manufactured empty to be filled at a later time. The device can also meter multiple fluids in separate reservoirs at the same time and mix the fluids, if needed. The invention has particular utility as a device for metering drugs and will be described in connection with such utility, although other utilities are contemplated.

This invention also includes further modifications and improvements of US pending application 20040234401, now abandoned, PCT application US2004/005922, PCT application US05/045210 and PCT application US07/73188 which are herein included in this application in their entirety.

Controlled delivery of fluids, such as drugs, in the medical and veterinary fields is accomplished by a variety of methods. One method of controlled prolonged delivery of beneficial agents involves the use of osmotic delivery systems. These devices can be external devices or implanted to release beneficial agents in a controlled manner over a pre-selected time or administration period. In general, osmotic delivery systems operate by absorbing fluid from the outside environment and releasing corresponding amounts of the beneficial agent. These devices are somewhat limited in use and practicality due to inaccuracies or delays in the time it takes for the device to absorb a fluid and start expelling fluid flow out of the device. This delay is caused by air pockets or voids that remain and get compressed during the start of the pump process Delayed start-up of beneficial fluids delivery is a significant problem in osmotic delivery systems.

This problem is solved by using a flexible actuator material that can be compressed when pump is assembled, creating a preloaded pressure condition that negates any dead airspace compression issues, that can delay the time it takes to start expelling the beneficial fluids. Because the actuator is already under pressure it starts delivering fluids as soon as the fluids are released from any restrictions on the fluid tubing, as the material relaxes outwardly when released. This allows time for the actuator material to start absorbing the hydrating fluids.

Another problem with osmotic pumps is that osmotic pressure often is too low to deliver many of the new more viscous pharmaceutical agents and materials. Methods and materials are described that overcome the osmotic pressure issues with the introduction of protonated molecular repulsive forces, that occur upon hydration of the flexible actuator material and can produce pressures in excess 50 psi. easily delivering most fluids.

Another problem that is solved by a flexible actuator material is that the device can now be made itself of flexible materials as long as these materials are, less flexible, or stiffer than the actuator material, the more flexible a device is the more desirable it is for comfort of the patient, animal or package configuration.

The invention in broad aspect provides a device for metering fluids comprising a fluid chamber with one inlet or outlet port, at last one sidewall and a movable separator that is in contact with and separates the fluid in the chamber from the other components of the device. The device includes a porous actuator housing and wicking material, a flexible polymer actuator material in contact with the porous actuator housing and the moveable separator, an actuator hydrating solution reservoir with at least one sidewall, an inlet port, and in fluid contact with porous actuator housing, and a fluid gate located at some point between actuator hydrating solution reservoir and the polymer actuator, effectively keeping the polymer actuator dry. An external shell holds all components on that the polymer actuator can only move in a direction and apply pressure to the separator in contact with the fluid in the fluid chamber, thereby dispensing fluid from fluid chamber.

In one aspect of the invention the fluid chamber is removable.

In another aspect of the invention the fluid chamber is made of a plastic, metal, glass, ceramic carbon or combination of these materials.

In another aspect of the invention the fluid chamber inlet/outlet port is capped or sealed by a pierce able septum.

In another aspect of the invention the movable separator is a rubber plunger.

In another aspect of the invention the movable separator is an elastomeric membrane and also a part of or attached to the fluid chamber.

In another aspect of the invention the porous actuator housing is made from plastic, metal, glass, ceramic, carbon or combination of these materials.

In another aspect of the invention the polymer actuator material is removable.

In another aspect of the invention the polymer actuator material is hydrophilic, or is a combination of hydrophilic and hydrophobic materials.

In another aspect of the invention the polymer actuator material, fluid gate, porous actuator housing, actuator hydrating solution reservoir are enclosed together as a sealed unit with an elastic membrane in contact with actuator material, with a port covered by a pierce able septum that allows filling and venting of the actuator hydrating solution reservoir with actuator hydrating solution.

In another aspect of the invention the fluid gate stopping actuator hydrating solution from contacting actuator is removable by the following methods of piercing, dissolving, tearing, pushing or by pulling gate out of hydrating solution path to allow hydration of the polymer actuator.

In another aspect of the invention the fluid gate is a membrane that can be torn, pierced or dissolved.

In another aspect of the invention the fluid gate can be opened and closed like a valve.

In another aspect of the invention the fluid in the fluid chamber is a medicine or has therapeutic value.

In another aspect of the invention the fluid camber can be filled in the device.

In another aspect of the invention the fluid chamber septum is pierced and the fluid is released into tubing that is in contact with a person or patient via a needle or other method that allows metering of released fluid to desired contact point.

In another aspect of the invention the fluid chamber septum is pierced and the fluid is released into tubing that is in contact with an animal via a needle or other method that allows metering of released fluid to desired contact point.

In another aspect of the invention the actuator material has varying layers of density and porosity.

In another aspect of the invention the actuator material has reacted and unreacted molecular sites.

In another aspect of the invention the actuator material has varying degrees of reacted and unreacted molecular sites.

In another aspect of the invention the actuator materials ratio of reacted to unreacted molecular sites determines the speed and pressure generation of the actuator material.

In another aspect of the invention protonation of reactive molecular sites within the actuator material, by interaction with the actuator hydrating solution or chemical byproduct of that interaction, determines the speed and pressure generation of the actuator material.

In another aspect of the invention the actuator materials density or porosity determines the speed and pressure generation of the actuator material.

In another aspect of the invention the amount of surface area of the actuator surface in fluid contact with the actuator hydrating solution via the porous actuator housing wicking material determines the speed and pressure generation of the actuator material.

In another aspect of the invention the actuator hydrating solution pH or chemical makeup determines the speed and pressure generation of the actuator material.

In another aspect of the invention, the device is implantable into a person, patient or animal.

In another aspect of the invention, the device utilizes body fluids as the actuator hydrating solution and has an opening in the exterior shell that allows the uptake of fluids by the actuator material.

The invention also provides in an alternative a device for metering fluids comprising two or more separate fluid chambers with one inlet or outlet port, at least one sidewall and a movable separator that is in contact with and separates the fluid in the fluid chambers from the other components of the device. The device includes a porous actuator housing and wicking material, a flexible polymer actuator material in contact with the porous actuator housing and the moveable separators, an actuator hydrating solution reservoir with at least one sidewall, an inlet port, and in fluid contact with porous actuator housing, a fluid gate located between each actuator hydrating solution reservoir and the polymer actuator. An external shell holds all components so that the polymer actuator can only move in a direction and apply pressure to the separator in contact with the fluid in the fluid chamber, thereby dispensing fluid from fluid chambers.

In one aspect of the alternative device one or more of the fluid chambers are removable.

In another aspect of the alternative device one or more of the fluid chambers are made of a plastic, metal, glass, ceramic carbon or combination of these materials.

In another aspect of the alternative device one or more of the fluid chambers inlet/outlet ports are capped or sealed by a pierce able septum.

In another aspect of the alternative device the movable separator is a rubber plunger.

In another aspect of the alternative device the movable separator is an elastomeric membrane and also a part of the fluid chamber.

In another aspect of the alternative device the porous actuator housing is made from plastic, metal, glass, ceramic, carbon or combination of these materials.

In another aspect of the alternative device the polymer actuator material is removable

In another aspect of the alternative device the polymer actuator material is hydrophilic, or is a combination of hydrophilic and hydrophobic materials.

In another aspect of the alternative device the polymer actuator material, fluid gate, porous actuator housing, actuator hydrating solution reservoir are enclosed together as a sealed unit with an elastic membrane in contact with actuator material, with a port covered by a pierce able septum that allows filling and venting of the actuator hydrating solution reservoir with actuator hydrating solution.

In another aspect of the alternative device the fluid gate stopping actuator hydrating solution from contacting actuator is removable or broken by the following methods piercing, dissolving, tearing, pushing or by pulling gate out of hydrating solution path to allow hydration of the polymer actuator.

In another aspect of the alternative device the fluid gate is a membrane that can be torn, pierced or dissolved.

In another aspect of the alternative device the fluid gate can be opened and closed like a valve.

In another aspect of the alternative device the fluids in the fluid chambers are a medicine or have therapeutic value.

In another aspect of the alternative device the fluid chambers can be filled in the device.

In another aspect of the alternative device the fluid chamber septums are pierced and the fluid is released into tubing that is in contact with a person or patient via a needle or other method that allows metering of released fluid to desired contact point.

In another aspect of the alternative device the fluid chamber septum is pierced and the fluid is released into tubing that is in contact with an animal via a needle or other method that allows metering of released fluid to desired contact point.

In another aspect of the alternative device the actuator material is an epoxy.

In another aspect of the alternative device the actuator material has varying layers of density and porosity.

In another aspect of the alternative device the actuator material has reacted and unreacted molecular sites.

In another aspect of the alternative device the actuator material has varying degrees of reacted and unreacted molecular sites.

In another aspect of the alternative device the actuator materials ratio of reacted to unreacted molecular sites determines the speed and pressure generation of the actuator material.

In another aspect of the alternative device the actuator materials density or porosity determines the speed and pressure generation of the actuator material.

In another aspect of the alternative device the amount of surface area of the actuator surface in fluid contact with the actuator hydrating solution via the porous actuator housing wicking material determines the speed and pressure generation of the actuator material

In another aspect of the alternative device the actuator hydrating solutions pH or chemical makeup determines the speed and pressure generation of the actuator material.

In another aspect of the alternative device there are one or more different actuator materials providing different speeds and pressures for one or more fluid chambers.

In yet another aspect of the alternative embodiment, the device is implantable into a person, patient or animal.

In the latter embodiment, the device utilizes body fluids as the actuator hydrating solution and has an opening in the exterior shell that allows the uptake of body fluids by the actuator material.

In still yet another embodiment of the invention there is provided a device for metering fluids comprising two or more separate fluid chambers with one or more inlet or outlet ports that are in fluid connection with a mixing chamber, and have at least one sidewall and a movable separator that is in contact with and separates the fluid in the fluid chambers from the other components of the device. The device includes a mixing chamber with one or more inlet port openings that are in fluid contact with the fluid chambers, and an exit port opening, that is in fluid contact with tubing or fluid channel or method to transport mixed fluids to desired delivery site. A porous actuator housing and wicking material, a flexible polymer actuator material in contact with the porous actuator housing and the moveable separators, an actuator hydrating solution reservoir with at least one sidewall, an inlet port, and in fluid contact with porous actuator housing, a fluid gate located between each actuator hydrating solution reservoir and the polymer actuator. An external shell holds all components so that the polymer actuator can only move in a direction and apply pressure to the separator in contact with the fluid in the fluid chamber, thereby dispensing fluid from fluid chambers.

In the still yet another embodiment one or more of the fluid chambers are made of a plastic, metal, glass, ceramic carbon or combination of these materials.

In the still yet another embodiment one or more of the fluid chambers inlet/outlet ports are capped or sealed by a pierce able septum.

In the still yet another embodiment the movable separator is a rubber plunger.

In the still yet another embodiment the movable separator is an elastomeric membrane and also a part of the fluid chamber.

In the still yet another embodiment the porous actuator housing is made from plastic, metal, glass, ceramic, carbon or combination of these materials.

In the still yet another embodiment the polymer actuator material is removable

In the still yet another embodiment the polymer actuator material is hydrophilic or is a combination of hydrophilic and hydrophobic materials.

In the still yet another embodiment the polymer actuator material, fluid gate, porous actuator housing, actuator hydrating solution reservoir are enclosed together as a sealed unit with an elastic membrane in contact with actuator material, with a port covered by a pierce able septum that allows filling and venting of the actuator hydrating solution reservoir with actuator hydrating solution.

In the still yet another embodiment the fluid gate stopping actuator hydrating solution from contacting actuator is removable or broken by the following methods piercing, dissolving, tearing, pushing or by pulling gate out of hydrating solution path to allow hydration of the polymer actuator.

In the still yet another embodiment the fluid gate is a membrane that can be torn, pierced or dissolved.

In the still yet another embodiment the fluid gate can be opened and closed like a valve.

In the still yet another embodiment the fluids in the fluid chambers are a medicine or have therapeutic value.

In the still yet another embodiment the fluid cambers can be filled in the device.

In the still yet another embodiment the mixing chamber exit port is capped or sealed by a septum, septum is pierced and the fluid is released into tubing that is in contact with a person or patient via a needle or other method that allows metering of released fluid to desired contact point.

In the still yet another embodiment the mixing chamber exit port is capped or sealed by a septum, septum is pierced and the fluid is released into tubing that is in contact with an animal via a needle or other method that allows metering of released fluid to desired contact point.

In the still yet another embodiment the actuator material is an epoxy.

In the still yet another embodiment the actuator material has varying layers of density and porosity.

In the still yet another embodiment the actuator material has reacted and un-reacted molecular sites.

In the still yet another embodiment the actuator material has varying degrees of reacted and un-reacted molecular sites.

In the still yet another embodiment the actuator materials ratio of reacted to un-reacted molecular sites determines the speed and pressure generation of the actuator material.

In the still yet another embodiment the actuator materials density or porosity determines the speed and pressure generation of the actuator material.

In the still yet another embodiment the amount of surface area of the actuator surface in fluid contact with the actuator hydrating solution via the porous actuator housing wicking material determines the speed and pressure generation of the actuator material

In the still yet another embodiment the actuator hydrating solutions pH or chemical makeup determines the speed and pressure generation of the actuator material.

In the still yet another embodiment there are one or more different actuator materials providing different speeds and pressures for one or more fluid chambers.

In yet another embodiment, the device is implantable into a person, patient or animal.

In the latter embodiment, the device utilizes body fluids as the actuator hydrating solution and has an opening in the exterior shell that allows the uptake of body fluids by the actuator material.

In yet another embodiment of the invention a two part insulin is mixed together at the prescribed ratio and metered after mixing to a patient via subcutaneous delivery.

In still yet another embodiment of the invention multiple types of medication, gene therapies, proteins etc. are metered to a patient via the best route to deliver the particular medications at the desired site on or in the patient.

Further features and advantages of the present invention will be seen from the following detailed description, taken in conjunction with the accompanying drawings, wherein

FIG. 1 schematically illustrates a representative embodiment of the invention;

FIG. 2 is a side cross-sectional view of an embodiment of the invention, and FIG. 2A is a view similar to FIG. 2 of a second embodiment of the invention;

FIG. 3 shows a single actuator;

FIG. 4 shows a plurality of actuators; and

FIG. 5 illustrates another embodiment of the invention.

Referring to the drawings, the present invention in one aspect comprises a chamber made in two parts that are assembled together with one or more inlet or outlet ports or openings (7) having tubing (7A) extended therethrough that are in fluid or gaseous connection with a mixing chamber 30. The displacement of the volume in the chamber is accomplished by using one or more but not limited to, polymers, co polymers, block polymers, hydro gels or epoxy materials that are hydrophilic and used as actuator material (1). For ease of illustration, FIG. 1 and FIG. 2 are not drawn to scale. Also, the exterior shell wall is illustrated in phantom in one dimension. The actuator material reacts by degrees of swelling to the chemical composition of the solution (4) hydrating the actuator material. The actuator hydrating fluid can range in pH from 0-14, depending on the actuator material, degree of swelling, pressure and displacement time required for the desired performance of the invention. The actuator material hydrating solution is kept separate from the fluid or gas being pumped or displaced by a flexible or moveable membrane, elastomeric or plunger material (5) that can stretch, move or slide as the fluid or gas volume (6) in the chamber is displaced by the actuator expansion or contraction and continue to keep a fluid or gas seal between the actuator hydrating fluid and the fluid or gas being pumped. The fluid chamber inlet and/or outlet may be capped or sealed by a piercable septum as shown in phantom at 34 in FIG. 2. FIG. 2A is similar to FIG. 2, but comprises two separate walled chambers with one or more fluid inlet or fluid outlet ports that are in fluid connection with a mixing chamber, etc., as described for FIG. 2.

One part of the ph responsive metering device or pump has one or more polymer actuator materials housed within or on a porous media substrate (2) that is less flexible than the actuator material. The second part of the chamber is a hollow shell, cavity or cylinder (3) made from material that is also less flexible than the actuator material. These fluid chamber materials can be made of but not limited to plastics, elastomeric material, glass, ceramics, metals and combinations of these. These are then housed in an external shell (8) for the form factor. All of the materials are standard in the relevant industry the device is used in and the performance requirements of the fluid or gaseous metering device or pump and are well known to experts in each field of use.

In one preferred embodiment, a flexible patch for liquid drug delivery, all of the parts are assembled by lamination techniques well know in the plastics industry, such as but not limited to glue, heat, pressure, UV irradiation, RF, or sonic welding. In the case of a cylinder or tube a. movable but fluid sealing plunger or piston (18) may be used. An example of this is a pre-filled medication vial or syringe such as but not limited to, the 3 ml glass vials or syringes used for insulin with an exit port covered by, capped or sealed by a septum shown at (20) at the chamber outlet end and rubber stopper that is pushed to dispense the fluid at the opposite end, which is open. The moveable rubber plunger or stopper keeps a sterile fluid seal but can be pushed to displace or dispense the medication once the septum is pierced and the medication is in fluid connection with a tube or needle that is able to inject medication into the patient. In both examples the fluid being metered or pumped is separate from the fluid used to hydrate the actuation material. The porous media is a ridged or semi ridged substrate or housing for the actuator material, it is also a fluid conduit to hydrate the actuator material. The porous material can be molded, extruded or stamped to allow geometric flexibility of the con figuration that makes up the complete device.

For example a medical device that uses industry standard medication vials such as but not limited to the 3 ml glass insulin vials or syringes, is typically referred to as an insulin syringe pump. These pumps are electronically controlled and driven by electric motors that turn very precise screw mechanisms in increments to push the syringe stopper and deliver small incremental doses of the insulin over a pre programmed time and rate.

The ph responsive pump uses the migration of the desired ph chemical solution through the polymer matrix and the resulting expansion or contraction as the mechanism to push the syringe stopper. As the polymer matrix expands or contracts it produces continuous pressure thereby offering continuous delivery rates. The speed of this reaction can be increased or decreased several ways.

By increasing the porosity of the polymer the speed increases or by decreasing the porosity of the polymer the actuation speed is decreased. The actuator material porosity can be adjusted by changing ratios of materials, adding catalysts or other materials that can be washed out with a solvent after the polymerization process, many methods are used dependent on the materials being used to make the actuator material and are well known within the polymer industry.

By increasing available external surface area of the actuator material the speed increases, the reverse is also true if you decrease available surface area, one way this is accomplished by stacking or assembling actuators together. For example a bundle of round strands (28) of actuator material provides a large amount of external surface area for rapid fluid migration, yet still provides good pushing force as it expands. Another actuator configuration to increase surface area is a hollow tube (9), as the actuator expands it is omni-directional and the center of a tube of the material allows a conduit for rapid uptake of fluid until it closes from the expansion.

In another preferred actuator or device configuration a fluid wicking material (10) that can be ridged, flexible or elastomeric is used. The wicking material adds a uniform fluid conduit or channel internally, through, along, in between or externally around the actuator material. The wicking material can be a hydrophobic or hydrophilic material that is compatible to the chemical fluid hydrating the actuator material. By inserting a wicking material either into or around the porous actuator material (not shown for the sake of simplifying the drawings) it provides a uniform hydration method that provides continuous pressure at the desired speed of expansion or contraction which results in a linear rate of fluid or gas displacement from the pump chamber. This solves the problem of increasing or decreasing pump or metering rate curves that develop as the actuator material expands or contracts and ratio of actuator surface area or exposed footprint to the actuator hydration fluid changes.

Yet another preferred actuation material configuration is a foamed actuator material this allows fast uptake of fluids, like a sponge, which results in faster actuation cycles or times. The increased surface area can also increases reaction surface area of the material, for example by incorporating primary, secondary or combinations of amines or other functional molecular groups in a polymer or actuator material, results in enhanced performance characteristics as the amines react to the ph of the hydrating solution in conjunction with the hydration effects of the actuator material.

The foaming can be accomplished by but not limited to the use of catalysts, emulsifiers, foaming agents, colloidal suspensions, heating, peroxides even whipping air into the liquid materials during polymerization can produce foamed actuation material. Oxidizing materials incorporated to add desired performance characteristics to the actuator materials can also result in foaming, these techniques are well known in the chemical and polymer industry.

Another preferred actuator material configuration is graduated porosity of the material. This actuator material can be made in one piece or by stacking layers of materials of different porosities and compositions together. One way of producing a one piece material is by adding layers of different porosity liquid actuator material into a mold, while still liquid each layer will mix slightly with the layer already in the mold and then the material can be polymerized or cured to produce the actuator material. Another way to produce the graduated porosity material is to pour each layer one at a time in the same mold, polymerize or cure it, then add the next liquid material layer and polymerize or cure it and continue adding layers until finished.

In another preferred embodiment the actuator material is kept dry and attached to the porous material or housed in it. The actuator hydrating solution is stored or kept separate from the actuator material by a thin film that is burst, pierced or dissolved when the device is started. The fluid is absorbed by or flows through the porous material and starts hydrating the actuator material starting the pumping or dispensing action. The embodiment also envisions having dissolving or time release capsules that can change the ph of the solution over time as the dissolve in the actuator hydrating solution, for example polymer actuators that have amines incorporated turn the hydrating solution to a basic ph of 9 or 10 over time, a slowly dissolving acidic chemical would extend and get the maximum time and pressure needed by the device because the amines react to the degree of the acid in the solution, these are all ways to control or engineer the performance of the device for a specific application.

Multiple actuators are another embodiment of the devices. The actuators are positioned in line or sequence. Sealed sections hold the actuator material and keep the actuator hydrating solution from each of the next in line or sequenced actuators. The pressure generated over time by the actuator material is used to open the next seal via puncture, bursting or physically opening a valve to allow fluid into the next section and to the actuator material and a progression of the actuators and actuator fluid can be controlled this way to engineer the performance of the devices for applications.

Preferred embodiments of the complete devices include a disposable one time liquid drug delivery patch that can be flexible and use disease, industry or manufacturers specific delivery routes or skin barrier technology to delivery the liquid drug through the patients skin and into the patient, for example a subcutaneous injection or infusion via needle and tubing another method is micro needle array, yet another is ionophoresis.

Another device embodiment is a one use cartridge that dispenses an industry or manufacturer's specific pre loaded liquid drug container and uses disease, industry or manufacturer's specific delivery routes to the patient, for example Insulin for diabetes can be delivered via a subcutaneous injection or infusion via needle and tubing in fluid connection to the drug container. By using a preloaded 3 ml vial of insulin the device can deliver a continuous pre determined rate of insulin to the patient, this is accomplished by the expansion characteristics of the actuator material that is used in the device to displace the insulin in the preloaded insulin vial.

Other device embodiments can also deliver bolus doses to the patient by have a predetermined bolus dose volume chamber in fluid connection with the delivery route and incorporating one way valves. A flexible membrane or covering that will deflect back to original shape once pressed is attached to one side or part of the bolus dose chamber and is physically pressed by the patient to dispense the bolus volume when needed. The one way valves allow the fluid to only travel in only one direction, towards the patient, to empty the bolus chamber and then the negative pressure in the dispensed chamber draws more fluid in from the fluid container over a predetermined time to refill bolus chamber for next bolus dose. Patient administered bolus doses are needed in many therapeutic protocols, pain and diabetes are examples of this need.

Other devices are envisioned that can use multiple liquid drug containers at the same time and mix the liquids prior to delivery or deliver separate liquids at different rates and pressures to the patient either directly as described above, or indirectly such as dispensing into an IV line or bag that will be or is attached to the patient and is delivering larger volumes of liquid drugs, hydrating or nutritional fluids. Chemotherapy, 2 part insulin, and antibiotics are all therapies that need this ability.

There are also many non medical uses for these devices such as pumping, mixing or dispensing chemicals over an extended period of time at predetermined rates. Mixing and dispensing 2 and 3 part epoxies at predetermined rates etc. The use of metering of gasses and gaseous flows can also be accomplished and is envisioned by the described inventions. The ability to engineer a device that produces a predetermined pressure at a predetermined rate over a predetermined time is very advantageous as many chemicals, glues, epoxies etc. are different viscosities so require the ability to be pumped or delivered at different pressures and rates.

The described inventions and components allow fluids and gaseous materials to be metered, pumped or dispensed in a low cost yet very accurate manner over extended time frames and pressures if needed. Multiple forms of the invention are described and are not meant to limit the scope of the inventions in any manner, shape, form factor or use.

The specific embodiments disclosed and illustrated herein should not be considered as limiting the scope of the invention, as understood by a person having ordinary skill in the art. Numerous variations are possible without falling outside the scope of the appended claims. The subject matter of the invention includes all novel and nonobvious combinations and subcombinations of the various elements, features, functions, and/or properties disclosed herein.

Banister, Mark, Fanter, Dale L.

Patent Priority Assignee Title
Patent Priority Assignee Title
3029743,
3922328,
4034380, Apr 08 1975 Ricoh Co., Ltd. Ink ejection apparatus for printer
4111202, Nov 22 1976 ALZA Corporation Osmotic system for the controlled and delivery of agent over time
4190411, Aug 04 1977 Kuraray Co., Ltd. Centrifugal potting apparatus
4203440, Oct 23 1978 ALZA Corporation Device having variable volume chamber for dispensing useful agent
4299220, May 03 1979 The Regents of the University of Minnesota Implantable drug infusion regulator
4327725, Nov 25 1980 ALZA Corporation Osmotic device with hydrogel driving member
4395719, Jan 05 1981 DATAPRODUCTS CORPORATION, A CORP OF CA Ink jet apparatus with a flexible piezoelectric member and method of operating same
4423166, Jul 20 1981 PPG Industries Ohio, Inc Ungelled polyepoxide-polyoxyalkylenepolyamine resins, aqueous dispersions thereof, and their use in cationic electrodeposition
4432699, May 04 1982 The Abet Group Peristaltic piezoelectric pump with internal load sensor
4449893, May 04 1982 The Abet Group Apparatus and method for piezoelectric pumping
4449983, Mar 22 1982 ALZA Corporation Simultaneous delivery of two drugs from unit delivery device
4507363, May 03 1984 Union Carbide Corporation Polyoxyalkyleneamine modified epoxy coatings for corroded metal surfaces
4538607, Feb 06 1984 AB Fixfabriken Tracheostomy valve
4551139, Feb 08 1982 Marion Laboratories, Inc. Method and apparatus for burn wound treatment
4559038, Oct 19 1984 SMITHS MEDICAL MD, INC Drug delivery system
4595583, Mar 19 1984 ALZA Corporation Delivery system controlled administration of beneficial agent to ruminants
4624847, Apr 22 1985 ALZA Corporation Drug delivery device for programmed delivery of beneficial drug
4624848, May 10 1984 Ciba-Geigy Corporation Active agent containing hydrogel devices wherein the active agent concentration profile contains a sigmoidal concentration gradient for improved constant release, their manufacture and use
4650469, Oct 19 1984 SMITHS MEDICAL MD, INC Drug delivery system
4655767, Oct 29 1984 DOW CORNING CORPORATION, THE, A CORP OF MICHIGAN Transdermal drug delivery devices with amine-resistant silicone adhesives
4663149, Mar 21 1984 ALZA Corporation Dispenser comprising inner and outer walls functioning as cooperative unit
4675174, Aug 16 1985 ALZA Corporation Veterinary dispenser delivering beneficial agent by gas power generated in situ
4723958, May 23 1986 Merck & Co., Inc. Pulsatile drug delivery system
4772474, Mar 19 1984 ALZA Corporation Dispenser with internal arrangement of lamina means for dispensing beneficial agent
4781714, Nov 02 1983 ALZA Corporation Dispenser for delivering thermo-responsive composition
4808084, Mar 24 1986 Hitachi, Ltd. Apparatus for transferring small amount of fluid
4810535, Feb 01 1988 PPG Industries Ohio, Inc Glycidol-modified polyepoxide-polyoxyalkylenepolyamine adducts
4842493, Nov 14 1986 QENICO AB, SAGVAGEN 12, A SWEDISH CORP Piezoelectric pump
4863456, Apr 30 1986 ALZA Corporation Dosage form with improved delivery capability
4948592, May 09 1986 ALZA Corporation Pulsed drug delivery
4963141, Aug 16 1985 ALZA Corporation Dispensing system for administering beneficial agent formulation to ruminants
5000957, Mar 19 1984 ALZA CORPORATION, A CORP OF DE Dispenser comprising hydrophilic osmopolymer
5034229, Dec 13 1988 ALZA Corporation Dispenser for increasing feed conversion of hog
5037420, Dec 13 1988 ALZA Corporation Delivery system comprising two sections for delivering somatotropin
5059423, Dec 13 1988 ALZA Corporation Delivery system comprising biocompatible beneficial agent formulation
5061242, Jul 18 1989 ARROW INTERVENTIONAL, INC , A CORP OF DE AWARE Adjustable implantable drug infusion system
5070560, Oct 22 1990 SPAN AMERICA MEDICAL SYSTEMS, INC Pressure relief support system for a mattress
5100933, Jan 28 1983 Massachusetts Institute of Technology Collapsible gel compositions
5105983, Oct 31 1989 I-Flow Corporation Infusion apparatus
5110596, Dec 13 1988 ALZA Corporation Delivery system comprising means for delivering agent to livestock
5175246, Jan 22 1992 University of Akron, The Medical grade adhesives and their preparation
5192197, Nov 27 1991 Rockwell International Corporation Piezoelectric pump
5232702, Jul 22 1991 Dow Corning Corporation Silicone pressure sensitive adhesive compositons for transdermal drug delivery devices and related medical devices
5246705, Apr 08 1992 CYGNUS, INC Occlusive, elastomeric backing materials in transdermal drug delivery systems, and associated methods of manufacture and use
5275853, Oct 03 1990 The Dow Chemical Company; DOW CHEMICAL COMPANY, THE Hydroxyl functionalized polyetheramines as barrier packaging for oxygen-sensitive materials
5279544, Mar 13 1992 Elan Pharma International Limited Transdermal or interdermal drug delivery devices
5279565, Feb 03 1993 LocalMed, Inc. Intravascular treatment apparatus and method
5284133, Jul 23 1992 ARMSTRONG PHARMACEUTICALS, INC Inhalation device with a dose-timer, an actuator mechanism, and patient compliance monitoring means
5300299, Jul 22 1991 Dow Corning Corporation Silicone pressure sensitive adhesive containing alkylmethylsiloxane wax and related methods and devices
5304121, Dec 28 1990 Boston Scientific Scimed, Inc Drug delivery system making use of a hydrogel polymer coating
5327041, Jul 05 1991 Rockwell International Corporation Biaxial transducer
5328696, Jul 22 1991 Dow Corning Corporation Devices using silicone pressure sensitive adhesives containing organic wax
5336057, Sep 30 1991 Nippon Densan Corporation Micropump with liquid-absorptive polymer gel actuator
5348746, Dec 06 1991 ALZA Corporation Method for administering drug
5354264, Oct 24 1991 Insutech, Inc. Gas pressure driven infusion system by hydrogel electrolysis
5376378, Feb 17 1993 Ciba-Geigy Corp. Copolymer of (meth)acryloxy-alkyl-siloxysilane and alkyl(meth)acrylates and the use thereof as pressure sensitive adhesives
5380760, Nov 19 1993 Minnesota Mining and Manufacturing Company Transdermal prostaglandin composition
5412821, Oct 22 1990 SPAN-AMERICA MEDICAL SYSTEMS, INC Pressure relief support system for a mattress
5429585, Jan 19 1993 Multi-function cushion
5431921, Sep 28 1990 Pfizer Inc Dispensing device containing a hydrophobic medium
5474783, Mar 04 1988 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
5498255, Aug 17 1993 ALZA Corporation Osmotic device for protracted pulsatile delivery of agent
5520643, Mar 01 1990 Michigan TransTech Corporation Implantable access devices
5546932, Mar 25 1992 Tebro SA Powder jet dispenser for medicament inhalation therapies
5573668, Oct 30 1990 Minnesota Mining and Manufacturing Company Hydrophilic microporous membrane for drug delivery devices and method for preparing same
5587237, Nov 17 1992 Ralf Korpman Associates, Inc. Pressure sensitive adhesive
5618899, May 02 1990 Crosslinked pressure-sensitive adhesives tolerant of alcohol-based excipients used in transdermal delivery devices and method of preparing same
5622482, Oct 31 1994 Daewood Electronics, Co., Ltd. Pump using shape memory alloys
5630709, Feb 09 1996 NATIONAL AERO AND SPACE ADMINISTRATION Pump having pistons and valves made of electroactive actuators
5633009, Nov 28 1990 AVEVA DRUG DELIVERY SYSTEMS, INC Transdermal administration of azapirones
5645855, Mar 13 1996 Ridge Scientific Enterprises, Inc. Adhesive compositions including polyvinylpyrrolidone acrylic acid polymers, and polyamines
5656286, Mar 04 1988 NOVEN PHARMACEUTICALS, INC Solubility parameter based drug delivery system and method for altering drug saturation concentration
5674192, Dec 28 1990 Boston Scientific Scimed, Inc Drug delivery
5687748, Jul 01 1996 R. J. Reynolds Tobacco Company Spool and shell with pressurizing fluid activated seal
5692256, Aug 04 1995 Hill-Rom Services, Inc Mattress for a hospital bed
5714160, Dec 13 1988 ALZA Corporation Delivery system comprising means for governing fluid ingress into the system
5718700, Sep 20 1994 ALZA Corporation Exit means in dosage form
5779668, Mar 29 1995 HOSPIRA, INC Syringe barrel for lyophilization, reconstitution and administration
5798600, Aug 29 1994 Oceaneering International, Inc.; STRESS ENGINEERING SERVICES, INC. Piezoelectric pumps
5810001, Jan 07 1994 AbbVie Inc Anesthetic transfer system
5823178, May 21 1993 Aradigm Corporation Disposable package for use in aerosolized delivery of drugs
5891463, Jul 03 1996 U S DERMATOLOGICS, INC Nonocclusive drug delivery device and process for its manufacture
5916968, Jan 17 1996 Henkel IP & Holding GmbH Adhesives resistant to skin-penetration enhancers
5939477, Feb 02 1998 Dow Corning Corporation Silicone pressure sensitive adhesive composition containing functionalized polyisobutylene
5951999, Feb 21 1997 Adhesives Research, Inc. Transdermal pressure sensitive adhesive drug delivery system
5954706, Dec 28 1990 Boston Scientific Corporation Drug delivery
5955549, May 29 1997 Rohm and Haas Company Crosslinked poly(amino acids) and method of preparation
5961298, Jun 25 1996 California Institute of Technology Traveling wave pump employing electroactive actuators
5979892, May 15 1998 Xerox Corporation Controlled cilia for object manipulation
5997501, Nov 18 1993 Alkermes Pharma Ireland Limited Intradermal drug delivery device
6004115, Dec 02 1994 Empresa Brasileira de Compressores S/A - Embraco Hermetic compressor for refrigeration systems
6010485, Sep 20 1996 Novo Nordisk A S Working cylinder
6024976, Jun 27 1991 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
6066325, Jun 18 1997 Baxter International Inc; BAXTER HEALTHCARE S A Fragmented polymeric compositions and methods for their use
6074178, Apr 15 1997 Face International Corp. Piezoelectrically actuated peristaltic pump
6074179, May 10 1999 The United States of America as represented by the Secretary of the Navy Magnetostrictive peristaltic pump
6106245, Oct 09 1997 Honeywell Low cost, high pumping rate electrostatically actuated mesopump
6109852, Nov 06 1996 Science & Technology Corporation @ UNM Soft actuators and artificial muscles
6143138, Aug 20 1998 The United States of America as represented by the Secretary of the Navy Visible light pH change for activating polymers and other pH dependent reactants
6152898, Apr 30 1999 Medtronic INC Overfill protection systems for implantable drug delivery devices
6157113, Mar 06 1998 Massachusetts Institute of Technology Conducting polymer generator-actuator with energy storage/recovery
6165155, Feb 07 1997 Sarcos LC Multipathway electronically-controlled drug delivery system
6174546, Feb 21 1997 Adhesives Research, Inc. Transdermal pressure sensitive adhesive drug delivery system
6180133, Nov 25 1997 ACTAVIS HOLDCO US, INC Antioxidant composition for topical/transdermal prevention and treatment of wrinkles
6183434, Jul 03 1996 Nitto Denko Corporation Multiple mechanical microporation of skin or mucosa
6184608, Dec 29 1998 Honeywell INC Polymer microactuator array with macroscopic force and displacement
6193996, Mar 25 1999 3M Innovative Properties Company Device for the transdermal delivery of diclofenac
6206850, Mar 14 1996 Christine, O'Neil; Alexander George Brian, O'Neil Patient controllable drug delivery system flow regulating means
6210712, Dec 05 1997 ALZA Corporation Dosage form having first and second coats
6213739, Jan 17 1997 Niagara Pump Corporation Linear peristaltic pump
6221383, Aug 11 1997 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
6223369, Nov 14 1997 SPAN-AMERICA MEDICAL SYSTEMS, INC Patient support surfaces
6249076, Apr 14 1998 Massachusetts Institute of Technology Conducting polymer actuator
6277401, May 07 1999 U.S. Dermatologics, Inc. Drug delivery device
6312715, May 01 1998 3M Innovative Properties Company Adhesive microsphere drug delivery composition
6316022, Jun 07 1995 NOVEN PHARMACEUTICALS, INC Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
6319245, Oct 09 1996 Drug delivery means
6336907, Nov 25 1998 PANASONIC ELECTRIC WORKS CO , LTD Massaging system
6337086, Feb 06 1999 Dow Silicones Corporation Pressure sensitive adhesive compositions for transdermal drug delivery devices
6352715, Feb 19 1998 Sagittarius Life Science Corp Transdermal rate-controlled delivery of Huperzine A for treatment of alzheimer's disease
6365178, Sep 06 1996 ALLERGAN SALES, LLC Method of making pressure sensitive adhesive matrix patches for transdermal drug delivery using hydrophilic salts of drugs and hydrophobic pressure sensitive adhesive dispersions
6365185, Mar 26 1998 CINCINNATI, UNIVERSITY OF Self-destructing, controlled release peroral drug delivery system
6368318, Jan 23 1998 W L GORE & ASSOCIATES, INC Opto-acoustic recanilization delivery system
6378292, Nov 10 2000 Honeywell International Inc.; Honeywell International Inc MEMS microthruster array
6387077, Oct 13 2000 Mallinckrodt Inc. Apparatus and method for providing a suspended agent
6392777, May 12 1997 Cambridge University Technical Services Limited Opto-mechanical device
6409716, Dec 15 1989 SciMed Life Systems, Inc. Drug delivery
6450773, Mar 13 2001 OL SECURITY LIMITED LIABILITY COMPANY Piezoelectric vacuum pump and method
6461644, Mar 25 1996 JACKSON, RICHARD R Anesthetizing plastics, drug delivery plastics, and related medical products, systems and methods
6464476, Dec 22 2000 Linear pump and method
6471686, Aug 11 1993 Drug delivery device
6475639, Jan 18 1996 SHAHINPOOR, MOHSEN Ionic polymer sensors and actuators
6490483, Feb 18 1999 VALERITAS, INC Electroactive pore
6531152, Sep 30 1998 DEXCEL PHARMA TECHNOLOGIES, LTD Immediate release gastrointestinal drug delivery system
6537194, Mar 24 1999 Hologic, Inc; Biolucent, LLC; Cytyc Corporation; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC ; Third Wave Technologies, INC; Gen-Probe Incorporated Catheter with permeable hydrogel membrane
6578245, Aug 31 1998 Eastman Kodak Company Method of making a print head
6586512, Sep 30 1999 Evonik Operations GmbH Binding superabsorbent polymers to substrates
6632522, Feb 16 1995 3M Innovative Properties Company Blended pressure-sensitive adhesives
6664718, Feb 09 2000 SRI International Monolithic electroactive polymers
6682318, Mar 03 1999 NGK Insulators, Ltd. Pump
6682500, Jan 29 1998 Synthetic muscle based diaphragm pump apparatuses
6685442, Feb 20 2002 National Technology & Engineering Solutions of Sandia, LLC Actuator device utilizing a conductive polymer gel
6726678, Feb 22 2001 REGENTS OF THE UNIVERSITY OF MINNEOSTA Implantable reservoir and system for delivery of a therapeutic agent
6766817, Jul 25 2001 Tubarc Technologies, LLC Fluid conduction utilizing a reversible unsaturated siphon with tubarc porosity action
6791003, Oct 11 1999 SAMYANG BIOPHARMACEUTICALS CORPORATION Dual adhesive transdermal drug delivery system
6796970, Jun 17 1997 Novo Nordisk A S Dose setting device
6809462, Apr 05 2000 SRI International Electroactive polymer sensors
6864295, Jul 23 2002 Asahi Kasei Chemicals Corporation Gas-generating, pressure-sensitive adhesive composition
6869275, Feb 14 2002 PHILIP MORRIS USA INC Piezoelectrically driven fluids pump and piezoelectric fluid valve
6876135, Oct 05 2001 SRI International Master/slave electroactive polymer systems
6902704, Feb 28 2002 Equistar Chemicals, L.P Injection pump assembly for a combinatorial reactor and related method
6940211, Jul 20 1999 SRI International Electroactive polymers transducers and actuators
6948636, Oct 31 2000 Onkoworks Gesellschaft fur Herstellung und Vertrieb Onkologischer Spezialpraparate mbH Device for administering liquids
6949079, Sep 03 1999 Fenwal, Inc Programmable, fluid pressure actuated blood processing systems and methods
6955923, Aug 24 2001 Roche Diagnostics Operations, Inc Device and method for investigating the flowability of a physiological fluid sample
6960864, Dec 25 2001 PANASONIC ELECTRIC WORKS CO , LTD Electroactive polymer actuator and diaphragm pump using the same
7285255, Dec 10 2002 Ecolab USA Inc Deodorizing and sanitizing employing a wicking device
7411792, Nov 18 2002 Washington State University Thermal switch, methods of use and manufacturing methods for same
7453187, Oct 25 2000 Washington State University Research Foundation Piezoelectric micro-transducers, methods of use and manufacturing methods for same
7458956, Nov 12 1999 Boston Scientific Scimed, Inc Apparatus for delivery of controlled doses of therapeutic drugs in endoluminal procedures
7544260, Oct 20 2004 Micro thruster, micro thruster array and polymer gas generator
7553903, Dec 19 2003 BASF Aktiengesellschaft Swellable hydrogel-forming polymers having a low fraction of fines
7700129, Mar 18 2004 Sony Corporation Polymer actuator
7820427, Nov 30 2001 FLUIDIGM CORPORATION - A DELAWARE CORPORATION Microfluidic device and methods of using same
8190270, Feb 08 2007 NeuroPace, Inc. Refillable reservoir lead systems
20010053383,
20020001571,
20020004064,
20020007014,
20020010412,
20020015733,
20020043895,
20020106402,
20020115740,
20020128572,
20020128618,
20020147208,
20020156463,
20020173745,
20020183738,
20020193754,
20030014036,
20030051292,
20030054025,
20030065303,
20030069359,
20030072792,
20030108590,
20030124189,
20030135158,
20030139495,
20030143257,
20030152616,
20030153900,
20030156953,
20030163099,
20030216683,
20030232198,
20040030262,
20040068224,
20040092865,
20040102762,
20040106893,
20040106894,
20040112442,
20040133159,
20040138603,
20040142023,
20040149288,
20040176502,
20040176748,
20040186419,
20040202708,
20040204677,
20040219194,
20040220548,
20040234401,
20040242709,
20040265545,
20050033230,
20050043657,
20050058695,
20050137577,
20050137578,
20050137579,
20050261631,
20050273081,
20050273082,
20050287214,
20060021614,
20060076540,
20060078603,
20060078604,
20060084942,
20060089619,
20060094985,
20060094989,
20060110596,
20060135911,
20060142478,
20060142875,
20060146475,
20060183216,
20060188558,
20060195057,
20060200083,
20060204532,
20060213674,
20060276744,
20070021697,
20070031495,
20070052139,
20070078376,
20070082038,
20070088267,
20070092570,
20070098771,
20070098772,
20070100355,
20070104771,
20070134310,
20070148218,
20070190150,
20070224253,
20070260201,
20070269522,
20070293826,
20080004421,
20080009800,
20080015494,
20080033228,
20080039791,
20080058706,
20080063698,
20080091139,
20080110463,
20080125744,
20080152592,
20080167641,
20080183144,
20080195018,
20080208107,
20080214987,
20080221552,
20080234656,
20080312610,
20080317615,
20090007904,
20090020521,
20090026069,
20090041833,
20090042970,
20090048555,
20090060986,
20090085444,
20090099545,
20090118662,
20090221971,
20090227988,
20090232685,
20090317442,
20100004638,
20100074953,
20110172645,
20130172180,
20130337566,
20140048558,
CA2477181,
CN1080829,
CN1934776,
DE19912606,
EP723982,
EP736556,
EP882890,
EP1454935,
JP2004261045,
JP2004269882,
JP2004514770,
JP2004826,
JP2005269773,
JP2006353034,
JP2008211915,
JP2009046649,
JP2137930,
JP5825326,
JP60235847,
JP8283540,
JP9287571,
RE35474, Oct 29 1984 Dow Corning Corporation Transdermal drug delivery devices with amine-resistant silicone adhesives
RE36754, Jun 06 1996 Dow Corning Corporation Devices using silicone pressure sensitive adhesives containing organic wax
WO28215,
WO244240,
WO2004031581,
WO2004076859,
WO2005061014,
WO2005118008,
WO2006065884,
WO2008079440,
WO2008129549,
WO2009069086,
WO2011032011,
WO9617170,
WO9620971,
WO9742412,
///
Executed onAssignorAssigneeConveyanceFrameReelDoc
Dec 03 2008MEDIPACS, INC.(assignment on the face of the patent)
Jun 02 2010BANISTER, MARKMEDIPACS, INC ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0248720714 pdf
Jun 08 2010FANTER, DALE L MEDIPACS, INC ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0248720714 pdf
Date Maintenance Fee Events
Dec 14 2021M2551: Payment of Maintenance Fee, 4th Yr, Small Entity.
Dec 14 2021M2554: Surcharge for late Payment, Small Entity.


Date Maintenance Schedule
Jun 12 20214 years fee payment window open
Dec 12 20216 months grace period start (w surcharge)
Jun 12 2022patent expiry (for year 4)
Jun 12 20242 years to revive unintentionally abandoned end. (for year 4)
Jun 12 20258 years fee payment window open
Dec 12 20256 months grace period start (w surcharge)
Jun 12 2026patent expiry (for year 8)
Jun 12 20282 years to revive unintentionally abandoned end. (for year 8)
Jun 12 202912 years fee payment window open
Dec 12 20296 months grace period start (w surcharge)
Jun 12 2030patent expiry (for year 12)
Jun 12 20322 years to revive unintentionally abandoned end. (for year 12)